Aperam

J.P. Morgan upgraded Aperam from neutral to overweight and set a €57 price target, implying upside potential of 21%. The bank expects that the EU import quotas for stainless steel, reduced since July 1, will support a price recovery and forecasts EBITDA of €757m for 2027, about 7% above consensus. For 2027 J.P. Morgan sees a free cash flow yield of roughly 15% for Aperam and expects accelerated EBITDA growth in the stainless steel segment versus 2025. » More on de.investing.com

Aperam reported adjusted Q1 EBITDA of €90m, slightly above analysts’ expectations of €87m and well up from €67m in the prior quarter, driven by a recovery in Europe and valuation effects. Segment contributions: Stainless & Electrical Steel €35m, Services & Solutions €20m, Alloys & Specialties €27m and Recycling & Renewables €23m. Free cash flow was negative €44m, net debt stood at €1.057bn; the savings program delivered €18m of savings in the quarter. For Q2 Aperam expects adjusted EBITDA to be significantly above the Q1 level and confirms full‑year EBITDA guidance near €488m. » More on de.investing.com

Aperam has launched the new, patented austenitic grade 316A, which offers comparable corrosion resistance and mechanical properties to 316L but is more cost-efficient with over 75% less molybdenum. The material is certified, available in wide dimensions for immediate use, and replaces 316L without adjustment of production parameters or tools. 316A uses a higher share of recycled content to support the EU taxonomy and has been tested for applications ranging from HVAC and food production to CCUS and electrolysis plants. » More on finanzen.net

Aperam delivered a solid adjusted EBITDA in Q4 2025, driven by recycling & renewables and by alloys and specialty materials. The company plans to invest €160 million in automation and new technologies over the next 3–4 years while strengthening supply‑chain synergies and innovative product offerings. Operating cash flow was €422 million and net debt was reduced. A higher EBITDA is expected for Q1 2026; the medium‑term target is a normalized annual EBITDA of €700–800 million. » More on de.investing.com

Aperam is expected to publish results for the quarter ended 31 December 2025 on 6 February 2026. Two analysts estimate an average loss of -$0.053 per share (previous year: $0.180 per share), and four analysts expect revenue to increase by 6.33% to around $1.67 billion. For the past fiscal year, six analysts on average forecast earnings of $0.151 per share and eight analysts forecast revenue averaging $7.19 billion (previous year: $6.77 billion). » More on finanzen.net